These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Role of aminoglycosides in the treatment of bacterial endocarditis. Graham JC; Gould FK J Antimicrob Chemother; 2002 Mar; 49(3):437-44. PubMed ID: 11864943 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis. Fadel HJ; Tleyjeh IM; Steckelberg JM; Wilson WR; Baddour LM Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1395-8. PubMed ID: 19705174 [TBL] [Abstract][Full Text] [Related]
54. The treatment of endocarditis by vancomycin. Newsom SW J Antimicrob Chemother; 1984 Dec; 14 Suppl D():79-84. PubMed ID: 6520068 [TBL] [Abstract][Full Text] [Related]
55. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Caputo GM; Archer GL; Calderwood SB; DiNubile MJ; Karchmer AW Am J Med; 1987 Oct; 83(4):619-25. PubMed ID: 3674050 [TBL] [Abstract][Full Text] [Related]
56. New evidence on the use of fosfomycin for bacteremia and infectious endocarditis. Veganzones J; Montero A; Maseda E Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):25-29. PubMed ID: 31131589 [TBL] [Abstract][Full Text] [Related]
57. The role of glycopeptide antibiotics in the treatment of infective endocarditis. Grüneberg RN; Antunes F; Chambers HF; Garau J; Graninger W; Menichetti F; Peetermans WE; Pittet D; Shah PM; Vogelaers D Int J Antimicrob Agents; 1999 Aug; 12(3):191-8. PubMed ID: 10461836 [TBL] [Abstract][Full Text] [Related]